Effects of acute amitriptyline administration on memory, anxiety and activity in male and female mice

Neuroscience Research Communications

Volumn 31, Issue 3, 2002, Pages 135-144

  Parra, Andrés ^a   Everss, Estrella ^a   Monleón, Santiago ^a   Vinader Caerols, Concepción ^a   Arenas, M Carmen ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Antidepressants; Elevated plus maze; Inhibitory avoidance; Memory consolidation; Retrograde amnesia

Indexed keywords

AMITRIPTYLINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; FEMALE; MALE; MAZE TEST; MEMORY CONSOLIDATION; MOUSE; NEUROPHARMACOLOGY; NONHUMAN; PHYSICAL ACTIVITY; PSYCHOPHARMACOLOGY; RETROGRADE AMNESIA; SEX DIFFERENCE; TRAINING; TRANQUILIZING ACTIVITY;

EID: 0036872756     PISSN: 08936609     EISSN: None     Source Type: Journal    
DOI: 10.1002/nrc.10046     Document Type: Article

References (43)

1. Baldessarini RJ. Drugs and the treatment of psychiatric disorders: depression and anxiety disorders. In: Hardman JG, Limbird LE, Gilman AG, editors. Goodman & Gilman's The pharmacological basis of therapeutics, 10th edition. New York: McGraw-Hill;2001. p 447-483.
2. Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977;266:730-2.
3. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 1997;8:523-32.
4. De Pablo JM, Parra A, Segovia S, Guillamon A. Learned immobility explains the behavior of rats in the forced swimming test. Physiol Behav. 1989;46:229-37.
5. Martos AJ, Vinader-Caerols C, Monleón S, Arenas MC, Parra A. Efectos de la fisostigmina y de la nicotina sobre la inmovilidad aprendida en la prueba de natación forzada. Psicothema 1999;11:631-9.
6. Parra A, Vinader-Caerols C, Monleón S, Simón VM. The learned immobility is also involved in the forced swimming test in mice. Psicothema 1999;11:239-46.
7. Dujardin K, Guerrien A, Leconte P. Sleep, brain activation and cognition. Physiol Behav 1990;47:1271-8.
8. Mondadori C, Waser P.G, Huston J.P. Time-dependent effects of post-trial reinforcement, punishment or ECS on passive avoidance learning. Physiol Behav 1977;18:1103-9.
9. Parra A. A common role for psychotropic medications: memory impairment. Med Hypotheses (in press).
10. Antikainen R, Hänninen T, Honkalampi K, Hintikka J, Koivumaa-Honkanen H, Tanskanen A, Viinamäki H. Mood improvement reduces memory complaints in depressed patients. Eur Arch Psychiatry Clin Neurosci 2001;251:6-11.
11. Riedel WJ, van Praag HM. Avoiding and managing anticholinergic effects of antidepressants. CNS Drugs 1995;3:245-59.
12. Yousef G, Ryan WJ, Lambert T, Pitt B, Kellett J. A preliminary report: a new scale to identify the pseudodementia syndrome. Int J Geriatr Psychiatry 1998;13:389-99.
13. Everss E, Arenas MC, Vinader-Caerols C, Monleón S, Parra A. Effects of amitriptyline on memory consolidation in male and female mice. Med Sci Res 1999;27:237-9.
14. Parra A, Martos A, Monleón S, Arenas MC, Vinader-Caerols C. Effects of acute and chronic maprotiline administration on inhibitory avoidance in male mice. Behav Brain Res 2000;109:1-7.
15. Monleón S, Casino A, Vinader-Caerols C, Arenas MC. Acute effects of fluoxetine on inhibitory avoidance consolidation in male and female OF1 mice. Neurosci Res Commun 2001;28:123-30.
16. Monleón S, Urquiza A, Arenas MC, Vinader-Caerols C, Parra A. Chronic administration of fluoxetine impairs inhibitory avoidance in male but not female mice. Behav Brain Res (in press).
17. Gold PE. The use of avoidance training in studies of modulation of memory storage. Behav Neural Biol 1986;46:87-98.
18. Stahl SM. Basic psychopharmacology of antidepressants. Part 1: Antidepressants have seven distinct mechanism of action. J Clin Psychiat 1998;59:5-14.
19. Feighner JP. Overview of antidepressants currently used to treat anxiety disorders. J Clin Psychiatry. 1999;60 Suppl 22:18-22.
20. Zethof TJ, Van der Heyden JA, Tolboom JT, Olivier B. Stress-induced hyperthermia as a putative anxiety model. Eur J Pharmacol. 1995;294:125-35.
21. Bodnoff SR, Suranyi-Cadotte B, Quirion R, Meaney MJ. A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology (Berl). 1989;97:277-9.
22. Griffiths RR, Weerts EM. Benzodiazepine self-administration in humans and laboratory animals -implications for problems of long-term use and abuse. Psychopharmacology (Berl). 1997;134:1-37.
23. Ögren SO, Cott JM, Hall H. Sedative/anxiolytic effects of antidepressants in animals. Acta Psychiatr Scand Suppl 1981;290:277-88.
24. File SE. Factors controlling measures of anxiety and responses to novelty in the mouse. Behav Brain Res 2001;125:151-7.
25. Heinsbroek R, Feenstra M, Boon P, van Haaren F, van de Poll N. Sex differences in passive avoidance depend on the integrity of the central serotoninergic system. Pharmacol Biochem Behav 1988;31:499-503.
26. Frackiewicz EJ, Sramek JJ, Cutler NR. Gender differences in depression and antidepressant pharmacokinetics and adverse events. Ann Pharmacother 2000;34:80-8.
27. Pellow S, Chopin P, File S, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 1985;14:149-67.
28. Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 1987;92:180-5.
29. File SE. Behavioural detection of anxiolitic action. In: Elliot JM, Heal DJ, Marsden CA, editors. Experimental approaches to anxiety and depression. Chichester: John Wiley & Sons, 1992, p 25-44.
30. StatSoft Inc. STATISTICA for Windows [Computer program manual]. Tulsa, OK: StatSoft Inc., 2000.
31. Kumar S, Kulkarni SK. Influence of antidepressant drugs on learning and memory paradigms in mice. Indian J Exp Biol 1996;34:431-5.
32. Shimizu-Sasamata M, Yamamoto M, Harada M. Cerebral activating properties of indeloxazine HC1 and its optical isomers. Pharmacol Biochem Behav 1993;45:335-41.
33. Takahashi K, Yamamoto M, Suzuki M, Ozawa Y, Yamaguchi T, Andoh H, Ishikawa K. Effects of cerebral metabolic enhancers on brain function in rodents. Curr Ther Res 1995;56:478-85.
34. Yamaguchi T, Takahashi K, Suzuki M, Yamamoto M, Andoh H, Ishikawa K. Effects of indeloxazine hydrochloride, a cerebral activator, on brain function in rodents. Curr Ther Res 1995;56:436-43.
35. Coudoré F, Fialip J, Eschalier A, Lavarenne J. Plasma and brain pharmacokinetics of amitriptyline and its dmethylated and hydroxylated metabolites after acute intraperitoneal injection in mice. Eur J Drug Metab Ph 1994;19:5-11.
36. Lamberty Y, Gower AJ. Investigation into sex-related differences in locomotor activity, place learning and passive avoidance responding in NMRI mice. Physiol Behav 1988;44:787-90.
37. Berger-Sweeney J, Arnold A, Gabeau D, Mills J. Sex differences in learning and memory in mice: effects of sequence of testing and cholinergic blockade. Behav Neurosci 1995;5:859-73.
38. Parra A, Arenas MC, Monleón S, Vinader-Caerols C, Simón VM. Sex differences in the effects of neuroleptics on escape-avoidance behavior in mice: A review. Pharmacol. Biochem Behav 1999;64:813-20.
39. Izquierdo I, Medina JH. GABAA receptor modulation of memory: the role of endogenous benzodiazepines. Trends Pharmacol Sci 1991;12:260-5.
40. Kameyama T, Nagasaka M, Yamada K. Effects of antidepressant drugs on a quickly-learned conditioned-suppression response in mice. Neuropharmacology 1985;24:285-90.
41. Casas J, Gilbert-Rahola J, Chover AJ, Micó JA. Test-dependent relationship of the antidepressant and analgesic effects of amitriptyline. Meth Find Exp Clin Pharmacol 1995;17:583-8.
42. Pavone F, Battaglia M, Sansone M. Prevention of amitriptyline-induced avoidance impairment by tacrine in mice. Behav. Brain Res 1997;89:229-36.
43. Brocco M, Dekeyne A, Veiga S, Girardon S, Millan MJ. Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents. Pharmacol Biochem Behav 2002;71:667-80.